Da Wei Huang
Impact in
- Cancer Research top 0.05%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Aging top 0.2%
Papers in
- Virology 6
- HIV Research and Treatment 6
- Co-authors
- Richard A. LempickiBrad T. ShermanRobert M. StephensMichael BaselerH. Clifford LaneDavid LiuYongjian GuoDavid Bryant
- Journals
- Blood (3 papers)The Journal of Infectious Diseases (3 papers)Journal of Agricultural and Food Chemistry (2 papers)Nucleic Acids Research (2 papers)Cancer Cell (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Da Wei Huang
64 papers receiving 44.8k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Cancer Research 8.6k
- Aging 781
- Molecular Biology 28.2k
- Immunology 5.4k
- Genetics 5.7k
Countries citing papers authored by Da Wei Huang
This map shows the geographic impact of Da Wei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Wei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Wei Huang more than expected).
Fields of papers citing papers by Da Wei Huang
This network shows the impact of papers produced by Da Wei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Wei Huang. The network helps show where Da Wei Huang may publish in the future.
Co-authors
The 25 scholars most cited alongside Da Wei Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 15 | |
| 6 | Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL Hit paper breakdown → | 2021 | 170 |
| 7 | 2018 | 22 | |
| 8 | 2018 | 48 | |
| 9 | 2016 | 20 | |
| 10 | 2015 | 7 | |
| 11 | 2014 | 3 | |
| 12 | 2013 | 42 | |
| 13 | 2013 | 78 | |
| 14 | 2012 | 40 | |
| 15 | 2011 | 12 | |
| 16 | Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists Hit paper breakdown → | 2008 | 11060 |
| 17 | DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists Hit paper breakdown → | 2007 | 1693 |
| 18 | 2007 | 440 | |
| 19 | 2001 | 110 | |
| 20 | 1997 | 353 |
About Da Wei Huang
Da Wei Huang is a scholar working on Nuclear Energy and Engineering, Virology, Genetics, Pathology and Forensic Medicine and Immunology, having authored 69 papers that have together received 45.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers), Bioinformatics and Genomic Networks (8 papers), Immune Cell Function and Interaction (7 papers), Concrete and Cement Materials Research (7 papers), Gene expression and cancer classification (7 papers), HIV Research and Treatment (6 papers) and Genomics and Phylogenetic Studies (5 papers). The work is most often cited by research in Cancer Research (8.6k citations), Aging (781 citations), Molecular Biology (28.2k citations), Immunology (5.4k citations) and Genetics (5.7k citations). Da Wei Huang has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Richard A. Lempicki, Brad T. Sherman, Robert M. Stephens, Michael Baseler, H. Clifford Lane, David Liu, Yongjian Guo, David Bryant, Xiaoli Jiao and Rebecca Kellum. Their work appears in journals such as Blood, The Journal of Infectious Diseases, Journal of Agricultural and Food Chemistry, Nucleic Acids Research and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.